Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06256484. IPD Sharing: NO. Countries: 2. Publications: 2.
Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00621452. IPD Sharing: Not stated. Countries: 1. Publications: 1.
BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL
ClinicalTrials.gov study NCT05370430. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase I/II Multiple Center Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell Malignancies
ClinicalTrials.gov study NCT03050190. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
ClinicalTrials.gov study NCT04099797. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT06830031. IPD Sharing: NO. Countries: 1. Publications: 4.
A Study of Improving the Efficacy of Treatment in Diffused Large B Cell Lymphoma Patients
ClinicalTrials.gov study NCT01793844. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT01466868. IPD Sharing: Not stated. Countries: 1. Publications: 31.
Study Evaluating Brexucabtagene Autoleucel (KTE-X19) in Pediatric and Adolescent Participants With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgki
ClinicalTrials.gov study NCT02625480. IPD Sharing: NO. Countries: 11. Publications: 1.
B-cell Immunity to Influenza (SLVP017)- Year 5, 2013
ClinicalTrials.gov study NCT03020537. IPD Sharing: NO. Countries: 0. Publications: 1.
First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL),
ClinicalTrials.gov study NCT05086315. IPD Sharing: YES. Countries: 5. Publications: 0.
A Study of Acalabrutinib and Vistusertib in Subjects With Relapsed/Refractory B-cell Malignancies
ClinicalTrials.gov study NCT03205046. IPD Sharing: YES. Countries: 2. Publications: 1.
Function and Composition of Regulatory B Cells in Participants With Glioblastoma
ClinicalTrials.gov study NCT04128774. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A comparatiVe Study on Efficacy and Safety of Lipegfilgrastim in Comparison to Pegfilgrastim in Elderly Patients With Aggressive B Cell Non-HOdgkin Lymphomas at hIgh Risk for R-CHOP-21-inDuced Neutrop
ClinicalTrials.gov study NCT02044276. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT02760485. IPD Sharing: YES. Countries: 1. Publications: 0.
Immunotherapy for High Risk/Relapsed CD19+ Acute Lymphoblastic Leukaemia, B-cell Non-Hodgkin's Lymphoma (B-NHL) and Chronic Lymphocytic Leukaemia (CLL)/ Small Lymphocytic Lymphoma (SLL) Using CAR T-ce
ClinicalTrials.gov study NCT02935257. IPD Sharing: NO. Countries: 1. Publications: 1.
Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00634881. IPD Sharing: NO. Countries: 1. Publications: 1.
CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malignancies
ClinicalTrials.gov study NCT02965092. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant
ClinicalTrials.gov study NCT01475058. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults w/ Recurrent or Refractory B Cell Malignancies
ClinicalTrials.gov study NCT03241940. IPD Sharing: NO. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.